Summary
The findings reported in this review present a number of avenues of approach to the study of the effects of drugs on children. Many investigators have begun to classify the behavior of disturbed children on a number of sophisticated, but operationally simple procedures which allow some dissection of the behavior deficits. This type of approach can lead to a better understanding not only of the pathological condition but also to a better understanding of the way in which a drug works.
An understanding of the manner in which amphetamines produce their therapeutic effect in the hyperkinetic child cannot be forthcoming from studies that only elaborate the pathological behavior. More attention must be paid to the function of the central and autonomic nervous systems and how these systems relate to the behavior of the child. Since many of the drugs that are useful in treating behavior problems in children have marked effects upon catecholamine levels in the brain, studies comparing urine catecholamine levels in various types of behavior disordered children after the administration of sympathomimetic amines might give specific direction to further research.
Finally, I think that some attention should be directed toward animal models for understanding some of the behavior disorders. Studies such as those of Young (1963, 1964 and 1966), with some modification, could be directed toward giving us a more complete grasp of the aberrant behavior seen in the human child. Animal models can complement studies in humans and they have the further advantage of allowing a more complete biochemical and neuropharmacological study of behavior.
Similar content being viewed by others
References
Abbott, P., Blake, A., Vincze, L.: Treatment of mentally retarded with thioridazine. Dis. nerv. Syst. 26, 583–585 (1965).
Alexandris, A., Lundell, F. W.: Effect of thioridazine, amphetamine and placebo on the hyperkinetic syndrome and cognitive area in mentally deficient children. Canad. med. Ass. J. 98, 92–96 (1968).
Bender, L., Collington, F.: The use of amphetamine sulfate (Benzedrine) in child psychiatry. Amer. J. Psychiat. 99, 116–121 (1942).
Bouthilet, L., Fisher, S.: Reference list on the use of psychopharmacological agents with children. In S. Fisher (Ed.): Child Research in Psychopharmacology, pp. 170–206. Springfield, Ill.: Ch. C. Thomas 1959.
Bradley, C.: The behavior of children receiving benzedrine. Amer. J. Psychiat. 94, 577–585 (1937).
—: Benzedrine and Dexedrine in the treatment of children's behavior disorder. Pediatrics 5, 24–36 (1950).
—, Bowen, M.: School performance of children receiving amphetamine (Benzedrine) Sulfate. Amer. J. Orthopsychiat. 10, 782–788 (1940).
— —: Amphetamine (Benzedrine) therapy of children's behavior disorders. Amer. J. Orthopsychiat. 11, 92–103 (1941).
Bradley, P. B., Key, B. J.: The effect of drugs on the arousal responses produced by electrical stimulation of the reticular formation of the brain. Electroenceph. clin. Neurophysiol. 10, 97–110 (1958).
Cochin, J., Kornetsky, C.: Development and loss of tolerance to morphine in the rat after single and multiple injections. J. Pharmacol. exp. Ther. 145, 1–10 (1964).
Cole, J.: The amphetamines in child psychiatry: A review. Semin. Psychiat. 1, 174–178 (1969).
Conners, C. K.: The effect of Dexedrine on rapid discrimination and motor control of hyperkinetic children under mild stress. J. nerv. ment. Dis. 142, 429–433 (1966).
—: The syndrome of minimal brain dysfunction. Psychological aspects. Pediat. Clin. N. Amer. 14, 749–766 (1967).
—, Eisenberg, L.: The effects of methylphenidate on symptomatology and learning in disturbed children. Amer. J. Psychiat. 120, 458–464 (1963).
— —, Barcai, A.: Effect of Dextroamphetamine on children: Studies on subjects with learning disabilities and school behavior problems. Arch. gen. Psychiat. 17, 478–485 (1967).
— —, Sharpe, L.: Effects of methylphenidate (Ritalin) on paired-associate learning and Porteus Maze performance in emotionally disturbed children. J. cons. Psychol. 28, 14–22 (1964).
—, Rothschild, G. H.: Drugs and learning in children. Learn. Disorders 3, 195–223 (1968).
Connolly, J. R.: Behavior disorders in mental retardates. Penn. med. J. 71, 67–69 (1968).
Denenberg, V.: Critical periods, stimulus input, and emotional reactivity: A theory of infantile stimulation. Psychol. Rev. 71, 335–351 (1964).
Eisenberg, L.: The management of the hyperkinetic child. Develop. med. Child Neurol. 8, 593–598 (1966).
Epstein, L. C., Lasagana, L., Conners, C. K., Rodriguez, A.: Correlation of Dextroamphetamine excretion and drug response in hyperkinetic children. J. nerv. ment. Dis. 146, 136–146 (1968).
Fish, B.: Drug therapy in child psychiatry: Pharmacological aspects. Comprehens. Psychiat. 1, 212–227 (1960).
- Methodology in child psychopharmacology. In D. H. Efron (Ed.): Psychopharmacology, A Review of Progress, 1957–1967, pp. 989–1001. PHS Publication No. 1836 (1968).
—, Shapiro, T.: A typology of children's psychiatric disorders. I. Its application to a controlled evaluation of treatment. J. Amer. Acad. Child Psychiat. 4, 32–52 (1965).
— —, Campbell, M.: Long-term prognosis and the response of schizophrenic children to drug therapy: A controlled study of Trifluoperazine. Amer. J. Psychiat. 123, 32–39 (1966).
— — —, Wile, R.: A classification of schizophrenic children under five years. Amer. J. Psychiat. 124, 1415–1423 (1968).
Fisher, S.: Child Research in Psychopharmacology. Springfield, Ill.: Ch. C. Thomas 1959.
Friedler, G.: The role of immune factors in the development of tolerance to morphine. Unpublished doctoral dissertation. Boston 1968.
—, Cochin, J.: Altered post-natal growth of pattern of offspring of female rats chronically treated with morphine prior to mating. Pharmacologist 9, 230 (1967).
— —: The effect of cross-fostering on growth patterns in offspring of morphinized and withdrawn female rats. Fed. Proc. 27, 754 (1968).
— —: Sensitivity and tolerance to morphine sulfate (MS) in the rat as affected by neonatal thymectomy or MS-pretreatment of the mother. Pharmacologist 10, 196 (1968).
Frosch, J., Wortes, S. B.: A contribution to the nosology of the impulse disorders. Amer. J. Psychiat. 111, 132–138 (1954).
Furchgott, R. F.: The pharmacology of vascular smooth muscle. Pharmacol. Rev. 7, 183–265 (1955).
Gastaut, H.: Combined photic and Metrazol activation of the brain. Electroenceph. clin. Neurophysiol. 2, 249–261 (1950).
—, Hunter, J.: An experimental study of the mechanism of photic activation in idiopathic epilepsy. Electroenceph. clin. Neurophysiol. 2, 263–287 (1950).
Grant, G. R.: Psychopharmacology in childhood emotional and mental disorders. J. Pediat. 61, 626–637 (1962).
Gunne, L. M., Lewander, T.: Brain catecholamines during chronic amphetamine intoxication. In A. Wikler (Ed.): The Addictive States. Baltimore: Williams and Wilkins 1968.
Hebb, D. O., Williams, K.: A method of rating animal intelligence. J. gen. Psychol. 34, 59–65 (1946).
Henley, W. L., Fisch, G. R.: Newborn narcotic withdrawal associated with regional enteritis in pregnancy. N. Y. J. Med. 66, 2565–2567 (1966).
Hoffeld, D. R., Webster, R. L.: Effect of injection of tranquilizing drugs during pregnancy on offspring. Nature (Lond.) 205, 1070–1072 (1965).
Hutt, C., Hutt, S. J.: Effects of environmental complexity on stereotyped behaviors of children. Anim. Behav. 13, 1–4 (1965).
— —, Lee, D., Ounsted, C.: Arousal and childhood autism. Nature (Lond.) 204, 902–909 (1964).
Jewett, R. E., Norton, S.: Effect of tranquilizing drugs on postnatal behavior. Exp. Neurol. 14, 33–43 (1966).
Killam, E. K.: Drug-action on the brain-stem reticular formation. Pharmacol. Rev. 14, 175–223 (1962).
Kornetsky, C.: Attention dysfunction and drugs in schizophrenia. In H. Brill, J. O. Cole, P. Deniker, H. Hippius and P. B. Bradley (Eds.): Neuro-Psycho-Pharmacology, pp. 948–954. Amsterdam: Excerpta Medica Foundation 1967.
—, Bain, G.: Morphine: Single-dose tolerance. Science 162, 1011–1012 (1968).
—, Eliasson, M.: Reticular stimulation and chlorpromazine: An animal model for schizophrenic overarousal. Science 165, 1273–1274 (1969).
Kovach, J.: Effects of autonomic drugs on imprinting. J. comp. physiol. Psychol. 57, 183–187 (1964).
—, Hess, E. H.: Effects of painful stimulation upon the following behavior in imprinting. J. comp. physiol. Psychol. 54, 461–464 (1963).
Laufer, M. W., Denhoff, E.: Hyperkinetic behavior syndrome in children. J. Pediat. 50, 463–474 (1957).
— —, Solomon, G.: Hyperkinetic impulse disorders in children's behavior problems. Psychosom. Med. 19, 38–49 (1957).
Lindsley, D. B., Henry, C. E.: Effects of drugs on behavior and the electroencephalograms of children with behavior disorders. Psychosom. Med. 4, 140–149 (1942).
Lytton, G. J., Knobel, M.: Diagnosis and treatment of behavior disorders in children. Dis. nerv. Syst. 20, 334–340 (1959).
Marazzi, A. S., Hart, E. R.: Comparison of the effects on evoked cortical synaptic response of mescaline, amphetamine and adrenalin. Electroenceph. clin. Neurophysiol. 5, 317–318 (1953).
Millichap, J. G.: Drugs in management of hyperkinetic and perceptually handicapped children. J. Amer. med. Ass. 206, 1527–1530 (1968).
—, Aymat, F., Sturgis, L. H.: Hyperkinetic behavior and learning disorders. Amer. J. Dis. Child. 116, 235–244 (1968).
—, Fowler, G.: Treatment of “minimal brain dysfunction” syndromes: Selection of drugs for children with hyperactivity and learning disabilities. Pediat. clin. N. Amer. 14, 767–777 (1967).
Molitch, M., Eccles, A. K.: Effect of Benzedrine Sulfate on intelligence scores of children. Amer. J. Psychiat. 94, 587–590 (1937).
—, Sullivan, J. P.: Effects of Benzedrine Sulfate on children taking the new Stanford Achievement Test. Amer. J. Orthopsychiat. 7, 519–522 (1937).
Moya, F., Thorndike, V.: The effects of drugs used in labor on the fetus and newborn. Clin. Pharmacol. Ther. 4, 628–653 (1963).
Nichols, M. M.: Acute alcohol withdrawal syndrome in a newborn. Amer. J. Dis. Child. 113, 714–715 (1967).
Ordy, J. M., Samorajski, T., Collins, R. L., Rolsten, C.: Prenatal chlorpromazine effects of liver, survival and behavior of mice offspring. J. Pharmacol. exp. Ther. 151, 110–125 (1966).
Orzack, M., Kornetzky, C.: The effects of daily administration of carphenazine on attention in the schizophrenic patient. Psychopharmacologia (Berl.) 11, 31–38 (1967).
Perlmutter, J. F.: Drug addiction in pregnant women. Amer. J. Obstet. Gynec. 99, 569–572 (1967).
Rushton, R., Steinberg, H.: Early experience and adult reactions to drugs. In D. Bente and P. B. Bradley (Eds.): Neuro-Psychopharmacology, pp. 345–346. Amsterdam: Elsevier Publishing Company 1965.
Rushton, R., Steinberg, H.: Reactions to drugs influenced by early experience. Anim. Behav. 14, 585–586 (1966).
Schaefer, O.: Alcohol withdrawal syndrome in a newborn infant of a Yukon Indian mother. Canad. med. Ass. J. 87, 1333–1334 (1962).
Stechler, G.: Newborn attention as affected by medication during labor. Science 144, 315–317 (1964).
Steinberg, H., Kumar, R., Kemp, I., Bartley, H.: Animal behavior studies and some possible implications for man. In C. W. M. Wilson (Ed.): The Pharmacological and Epidemiological Aspects of Adolescent Drug Dependence, pp. 29 to 40. Oxford: Pergamon 1968.
Stern, R.: The pregnant addict. A Study of 66 case histories. Amer. J. Obstet. Gynec. 94, 253–257 (1966).
Thompson, T., Schuster, C. R.: Behavioral Pharmacology. Englewood Cliffs: Prentice-Hall 1968.
Udenfriend, S.: Physiological regulation of noradrenalin biosynthesis. In G. E. Wolstenholme and M. O'Connor (Eds.): Adrenergic Transmission, pp. 3–15. Ciba Foundation Study Group No. 33. Boston: Little, Brown 1968.
Van Leeuwen, G., Guthrie, R., Stange, F.: Narcotic withdrawal reaction in a newborn infant due to codeine. Pediatrics 36, 635–636 (1965).
Werboff, J.: Tranquilizers in pregnancy and behavioral effects on the offspring. Nature (Lond.) 209, 110–111 (1966).
—, Kesner, R.: Learning deficits of offspring after administration of tranquilizing drugs to the mother. Nature (Lond.) 197, 106–107 (1963).
Werry, J. S.: Developmental hyperactivity. Pediat. Clin. N. Amer. 15, 581–599 (1968).
—, Weiss, G., Douglas, V., Martin, J.: Studies on the hyperactive child. III. The effect of chlorpromazine upon behavior and learning ability. J. Amer. Acad. Child Psychiat. 5, 292–312 (1966).
Yaffee, S., Krasner, J., Catz, C. S.: Variations in detoxication enzymes during mammalian development. Ann. N. Y. Acad. Sci. 151, 887–899 (1968).
Yeary, R. A., Benish, R. A., Finkelstein, M.: Acute toxicity of drugs in newborn animals. J. Ped. 69, 663–667 (1966).
Yerby, A.: Problem of neonatal narcotic addiction. N. Y. J. med. 66, 1248–1249 (1966).
Young, R. D.: Effects of prenatal maternal injection of epinephrine on postnatal offspring behavior. J. comp. physiol. Psychol. 56, 929–932 (1963).
—: Effect of prenatal drugs and neonatal stimulation on later behavior. J. comp. physiol. Psychol. 58, 309–311 (1964).
—, Klepinger, B.: Effect of neonatal catecholamine administration on later behavior in rats. Psychopharmacologia (Berl.) 8, 445–453 (1966).
Author information
Authors and Affiliations
Additional information
Thanks are due to Mrs. Marcia Ford of the Francis A. Countway Library of Medicine of Harvard University for her help in facilitating and conducting a Medlars literature search.
Research Scientist Awardee MH 1759 of the National Institute of Mental Health. The preparation of this review was supported in part by Grant MH 12568 from the National Institute of Mental Health.
Rights and permissions
About this article
Cite this article
Kornetsky, C. Psychoactive drugs in the immature organism. Psychopharmacologia 17, 105–136 (1970). https://doi.org/10.1007/BF00402703
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00402703